DEC 27, 2018 4:13 PM PST

Unapproved Stem Cell Treatments Sickened Over a Dozen People Last Year

WRITTEN BY: Carmen Leitch

The Centers for Disease Control and Prevention (CDC) found that at least a dozen people were sickened last year by unapproved stem cell treatments. Three of those patients were subjected to procedures with reagents made by Genetech, Inc. That company and others have been warned by the Food and Drug Administration (FDA) to correct the violations they have been notified about, and that failure to do so may result in “seizure or injunction.”

“The FDA is committed to advancing the field of cell-based regenerative medicine. We’re implementing new policies to make it more efficient to safely develop these promising new technologies. At the same time, we’re also focusing more resources on enforcement when we see companies skirt safety measures and put patients at risk. In this case, the company’s failure to put in place appropriate safeguards may have led to serious blood infections in patients,” said FDA Commissioner Scott Gottlieb, M.D. in a statement.

“We remain committed to supporting the development of safe and effective cell-based regenerative medicine and advancing our comprehensive regenerative medicine policy framework. These efforts include our work to encourage manufacturers to engage with the FDA early so that we can provide guidance about any applicable regulatory requirements. Even though a few sponsors have come to us, we are discouraged by the overall lack of manufacturers wanting to interact with the agency in this enforcement discretion period. The letters we’re issuing today to manufacturers, health care providers and clinics around the country are a reminder that there’s a clear line between appropriate development of these products and practices that sidestep important regulatory controls needed to protect patients. Time is running out for firms to come into compliance during our period of enforcement discretion. We’ll be increasing our oversight related to cell-based regenerative medicine as part of our comprehensive plan to promote beneficial innovation while protecting patients.”

Sources: CDC, FDA

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUL 18, 2020
Space & Astronomy
Closest Ever Images of the Sun Expose Previously Unknown Features
JUL 18, 2020
Closest Ever Images of the Sun Expose Previously Unknown Features
New images from the Solar Orbiter, a joint project between NASA and the European Space Agency (ESA) that launched in Feb ...
AUG 14, 2020
Plants & Animals
Tracking the Iconic American Bison
AUG 14, 2020
Tracking the Iconic American Bison
The Great Plains of Montana are home to one of the United States' largest land restoration projects, known as the Am ...
SEP 11, 2020
Chemistry & Physics
The Rise of (Micro)Robots
SEP 11, 2020
The Rise of (Micro)Robots
As reflected by Moore's law, the semiconductor industry has observed a tremendous growth in microelectronics in the ...
SEP 18, 2020
Chemistry & Physics
Toward Understanding Anesthesia
SEP 18, 2020
Toward Understanding Anesthesia
General anesthesia refers to the medical procedure anesthesiologists applies to patients, in order to induce paraly ...
OCT 03, 2020
Space & Astronomy
NASA Launches $23m Toilet to Space Station
OCT 03, 2020
NASA Launches $23m Toilet to Space Station
On late October 2nd, NASA launched a spacecraft carrying 4 tonnes of cargo, including scientific equipment, food hardwar ...
OCT 22, 2020
Chemistry & Physics
NASA Looks to Nuclear Fusion for Powering Deep Space Missions
OCT 22, 2020
NASA Looks to Nuclear Fusion for Powering Deep Space Missions
Nuclear fusion is the frontier of energy research, and NASA has a plan to bring this state-of-the-art power source to th ...
Loading Comments...